Weekly intraperitoneal injections (250 μg) of MC1, DA31 or PHF1 were administered to different cohorts of mice carrying the P301L tau mutation responsible for frontotemporal dementia in humans. The gene discussed is PHF1; the disease is frontotemporal dementia.